Price
CHART BY
Frequently asked questions
What is Demant's market capitalization?
The market capitalization of Demant is 51.39B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Demant's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Demant is 22.50. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Demant?
Demant's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $11.17. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Demant's stock?
Currently, 22 analysts cover Demant's stock, with a consensus target price of 280.70. Analyst ratings provide insights into the stock's expected performance.
What is Demant's revenue over the trailing twelve months?
Over the trailing twelve months, Demant reported a revenue of 22.42B.
What is the EBITDA for Demant?
Demant's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 6.14B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Demant?
Demant has a free cash flow of 3.26B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Demant have, and what sector and industry does it belong to?
Demant employs approximately 21,349 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Demant's shares?
The free float of Demant is 82.15M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 51.39B
- EPS (TTM)
- $11.17
- Free Float
- 82.15M
- P/E ratio (TTM)
- 22.50
- Revenue (TTM)
- 22.42B
- EBITDA (TTM)
- 6.14B
- Free Cashflow (TTM)
- 3.26B
Pricing
- 1D span
- $36.68$38.03
- 52W span
- $29.57$50.92
Analyst Ratings
The price target is 280.70 and the stock is covered by 22 analysts.
Buy
11
Hold
9
Sell
2
Information
Demant A/S engages in the development, manufacture, and sale of products and equipment designed to aid the hearing and communication of individuals. It operates through the following geographical segments: Europe, North America, Asia, Pacific Region, and Rest of World. The company was founded by Hans Demant in 1904 and is headquartered in Smorum, Denmark.
- Employees
- 21,349
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- DK0060738599
- Primary Ticker
- DEMANT
Knockouts
LSX Data · Fundamentals & EOD data from FactSet